Bettina is working on targeted mRNA delivery for the treatment of hereditary conditions and cancers.
Bettina Dietmair has a background in molecular engineering and bionanotechnology across roles in industry and academia. She is an affiliate researcher at the National Biologics Facility – UQ, and joined Associate Professor Seth Cheetham‘s group for her PhD. Her work on targeted delivery of lipid nanoparticles has been recognised with the Best of Molecular Therapy Nucleic Acids Award 2025. By expanding the reach of cell-specific delivery, her research aims to enable the development of mRNA therapeutics for a broad range of extrahepatic conditions.
Key Publications
Dietmair*, Humphries*, Mercer, Thurecht, Howard, Cheetham. Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell surface markers. Mol Ther Nucleic Acids. 2025 Mar 19;36(2):102520.
Wong, Lam, Coleborn, Jose, Alim, Tu, Antczak, Dietmair, Golbaz Hagh, Noronha, Cheetham, Hooper, Beavis, Merino, Berthelet, Aoude, McCart-Reed, Lakhani, Simpson, Rossi, Brooks, Jones, Simpson, Souza-Fonseca-Guimaraes. Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy. Mol Ther. 2026 Mar 4;34(3):11.021.